Efloxate

CAS : 119-41-5

Ref. 3D-AAA11941

Informations sur le produit

• Nom: Efloxate
• Synonymes: ((4-Oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy)acetic acid ethyl ester, Efloxatum, UNII-CZU6V3902K, Coril, 7-Flavone ethyl hydroxyacetate, Eflossato, Ethyl 7-hydroxyflavone, Ethyl 7-flavonoxyacetate, BRN 0313027, Efloxate, CCRIS 5253, Flacethyle, Efloxato [INN-Spanish], Domucor, Efloxato, Oxiflavil, Flavone-7-ethyl-oxyacetate, Ethyl [(4-oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy]acetate, Ethyl flavon-7-yloxyacetate, Acetic acid, [(4-oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy]-, ethyl ester, 4-18-00-00695 (Beilstein Handbook Reference), 7-Flavonoxyacetic acid ethyl ester, 7-alpha-(Acetoxyethane)-oxyflavone, Dilatan kore, RE 1-0185, Eflossato [DCIT], REC 1-0185, ethyl [(4-oxo-2-phenyl-4H-chromen-7-yl)oxy]acetate, Flacethyle, Efloxate [INN:JAN], Acetic acid, 2-[(4-oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy]-, ethyl ester, Ethyl-((4-oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy) acetate, Angorlisin, Corosanin, Oxyflavil, Acetic acid, ((4-oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy)-, ethyl ester, Recordil, Ethyl flavone-7-oxyacetate

Description

Efloxate is a collagen analog that inhibits the activity of the enzyme lysyl oxidase. This inhibition prevents the cross-linking of collagen and leads to a reduction in collagen production and tissue hardening. Efloxate has been approved by the FDA for treatment of cardiac disease, autoimmune diseases, and some cancers. The drug also has anti-inflammatory properties, which may be due to its ability to inhibit inflammatory bowel disease.
Efloxate is absorbed from the gastrointestinal tract after oral administration and has been shown to have an absorption enhancer activity in rats with colitis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 324.3 g/mol
• Formule: C₁₉H₁₆O₅
• Degré de pureté: Min. 95%